A recent study by Meisel and colleagues utilizing a mouse model of TET2 deficiency (mimicking one of the commonly identified mutations in CH) suggested that mice with this genotype require impaired GI barrier function in order to develop CH. This evidence concerns the gene TET2 and cyclic hematopoiesis.